Position in JNJ
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$10,788,391
+$240,072 QoQ
Shares Held
42,479
-1.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.45%
of 13F equity value
Holder Rank
#1,067
of 4,676 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Apella Capital, LLC holds $29,919,337 across 10 Drug Manufacturers - General names. JNJ ranks #1 (36.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
42,479 | $10,788,391 | |
| 2 | ABBV |
AbbVie Inc.
|
20,565 | $5,174,976 | |
| 3 | LLY |
ELI LILLY & Co
|
4,276 | $5,128,763 | |
| 4 | MRK |
Merck & Co., Inc.
|
37,663 | $4,839,695 | |
| 5 | PFE |
Pfizer Inc
|
46,600 | $1,122,128 | |
| 6 | AMGN |
Amgen Inc
|
2,984 | $1,080,566 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
12,792 | $737,075 | |
| 8 | NVS |
Novartis AG
|
2,960 | $463,891 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,788,391 | 42,479 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $10,548,319 | 43,153 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $6,501,748 | 31,417 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $5,652,899 | 30,487 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $4,403,477 | 28,828 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $4,585,310 | 27,649 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $3,519,327 | 24,335 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $3,887,333 | 23,987 | Shares | Sole | 2024-10-03 | |
| 2024-06-30 | $3,396,027 | 23,235 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $3,065,722 | 19,380 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $3,050,630 | 19,463 | Shares | Sole | 2024-01-05 | |
| 2023-09-30 | $2,071,319 | 13,299 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $2,235,678 | 13,507 | Shares | Sole | 2023-07-06 | |
| 2022-12-31 | $2,305,105 | 13,049 | Shares | Sole | 2023-01-10 | |
| 2022-09-30 | $1,515,164 | 9,275 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $1,782,732 | 10,043 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $1,536,938 | 8,672 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $1,439,040 | 8,412 | Shares | Sole | 2022-01-13 | |
| 2021-09-30 | $1,162,154 | 7,196 | Shares | Sole | 2022-01-18 | |
| 2021-06-30 | $1,331,428 | 8,082 | Shares | Sole | 2022-01-18 | |
| 2021-03-31 | $1,421,298 | 8,648 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $1,341,821 | 8,526 | Shares | Sole | 2021-02-18 | |
| 2020-09-30 | $1,363,145 | 9,156 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $1,280,717 | 9,107 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $1,181,087 | 9,007 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||